highperformr logo

Carmine Therapeutics's Overview

Total employees8
HeadquartersCambridge
Founded2019

Carmine Therapeutics is a biotechnology company focused on harnessing the unique properties of red blood cell extracellular vesicles (RBCEVs) to develop powerful, non-viral gene therapies. Their proprietary REGENT™ platform aims to overcome the limitations of current viral-based gene therapies, offering the potential for repeat dosing, larger payload capacity, and a better safety profile. Carmine is advancing a pipeline of therapeutics for a range of genetic and rare diseases, with a mission to deliver transformative treatments to patients in need.

Where is Carmine Therapeutics's Headquarters?

HQ Function

Serves as the primary center for corporate strategy, research leadership, business development, clinical operations, and administrative functions.

Notable Features:

Situated within a vibrant biotech hub, providing access to state-of-the-art laboratory facilities and a collaborative ecosystem of research institutions and partner companies.

Work Culture:

A science-driven, innovative, and collaborative environment. Employees are typically passionate about advancing gene therapy and making a difference in patients' lives, working in a fast-paced, dynamic setting.

HQ Significance:

The Cambridge location provides unparalleled access to top-tier talent, leading academic research, venture capital, and potential pharmaceutical partners, crucial for a pioneering biotech firm.

Values Reflected in HQ: Innovation, scientific rigor, collaboration, and a commitment to translating cutting-edge science into patient therapies.

Location:

Carmine Therapeutics operates with key research and development hubs in North America (Cambridge, MA) and Asia (Singapore). This dual presence allows them to leverage talent, resources, and collaborative opportunities in two major global biotech centers, supporting their efforts in platform development, pipeline advancement, and strategic partnerships worldwide.

Street Address:

200 Technology Square, Suite 230

City:

Cambridge

State/Province:

MA

Country:

USA

Carmine Therapeutics's Global Presence

Singapore, Singapore

Address: Discovery Centre, 45 Nanyang Drive, #02-02, Singapore 637460 (Note: This is an address associated with EVX Ventures, a key founder/investor; specific Carmine R&D site in Singapore may be within a research park like Biopolis or associated with NUS Enterprise)

To advance core RBCEV technology, foster collaborations within the Asia-Pacific biotech ecosystem, and support global R&D programs. Taps into Singapore's strong biomedical research infrastructure.

Buying Intent Signals for Carmine Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Carmine Therapeutics

As of April 2025, Carmine Therapeutics' leadership includes:

Xingfeng Bao, PhD - Co-founder & Chief Executive Officer
Minh Le, PhD - Chief Business Officer
Eliseo Salinas, MD, MSc - Chief Development Officer
Jurgi Camblong, PhD - Chairman of the Board

Investors of Carmine Therapeutics

Carmine Therapeutics has been backed by several prominent investors over the years, including:

EVX Ventures
Takeda Ventures, Inc.
Panacea Venture
Viva BioInnovator
ShangBay Capital
Huagai Capital
Simiao Equity Investment

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past 12-18 months, Carmine Therapeutics appointed its co-founder Xingfeng Bao as CEO and strengthened its clinical development capabilities with the hiring of Eliseo Salinas as Chief Development Officer.

Departures

Don Haut, PhD, Don Haut transitioned from his role as CEO, with co-founder Xingfeng Bao appointed as successor.

New Appointments:

Xingfeng Bao, PhD, Xingfeng Bao, co-founder, was appointed Chief Executive Officer.
Eliseo Salinas, MD, MSc, Eliseo Salinas, MD, MSc, joined Carmine Therapeutics as Chief Development Officer.

Technology (Tech Stack) used by Carmine Therapeutics

Discover the tools Carmine Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Carmine Therapeutics Email Formats and Examples

While not publicly confirmed, biotechnology companies of Carmine Therapeutics's size often use common email patterns. The most likely format is [first_initial][last]@carminetherapeutics.com or [first].[last]@carminetherapeutics.com.

[first_initial][last]@carminetherapeutics.com

Format

xbao@carminetherapeutics.com

Example

70%

Success rate

News and media

PR NewswireMay 16, 2023

Carmine Therapeutics Appoints Eliseo Salinas, MD, MSc, as Chief Development Officer

Carmine Therapeutics announced the appointment of Eliseo Salinas, MD, MSc, as its Chief Development Officer. Dr. Salinas brings extensive experience in clinical development and regulatory affairs to lead Carmine's efforts in advancing its novel gene therapies through clinical trials....more

PR NewswireJanuary 05, 2023

Carmine Therapeutics Appoints Co-Founder Xingfeng Bao, Ph.D., as Chief Executive Officer

Carmine Therapeutics announced that its Board of Directors has appointed Co-founder Xingfeng Bao, Ph.D., as Chief Executive Officer, effective immediately. He succeeds Don Haut, Ph.D., who will transition from the Company....more

TakedaMarch 30, 2021

Carmine Therapeutics and Takeda Announce Research Collaboration to Develop and Commercialize Non-Viral Gene Therapies for Two Rare Diseases

Carmine Therapeutics and Takeda Pharmaceutical Company Limited announced a research collaboration and license agreement to discover, develop, and commercialize non-viral gene therapies for two rare disease targets using Carmine's REGENT™ Platform. The deal included upfront payment, milestones up to $900M and royalties....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Carmine Therapeutics, are just a search away.